Other genes associated to breast cancer risk included in the NCCN guidelines are BARD1, BRIP1, MSH2, MLH1, MSH6, PMS2, RAD51C, and RAD51D, but they are not considered for breast cancer management and assessment [16]. This evidence concerns the gene MSH2 and breast carcinoma.